Skip to main content
Biophysical Journal logoLink to Biophysical Journal
. 2022 Nov 9;121(23):4467–4475. doi: 10.1016/j.bpj.2022.11.002

Measuring single-virus fusion kinetics using an assay for nucleic acid exposure

Ana M Villamil Giraldo 1, Steinar Mannsverk 1, Peter M Kasson 1,2,
PMCID: PMC9748363  PMID: 36330566

Abstract

The kinetics by which individual enveloped viruses fuse with membranes provide an important window into viral-entry mechanisms. We have developed a real-time assay using fluorescent probes for single-virus genome exposure than can report on stages of viral entry including or subsequent to fusion pore formation and prior to viral genome trafficking. We accomplish this using oxazole yellow nucleic-acid-binding dyes, which can be encapsulated in the lumen of target membranes to permit specific detection of fusion events. Since increased fluorescence of the dye occurs only when it encounters viral genome via a fusion pore and binds, this assay excludes content leakage without fusion. Using this assay, we show that influenza virus fuses with liposomes of different sizes with indistinguishable kinetics by both testing liposomes extruded through pores of different radii and showing that the fusion kinetics of individual liposomes are uncorrelated with the size of the liposome. These results suggest that the starting curvature of such liposomes does not control the rate-limiting steps in influenza entry.

Significance

Enveloped viral entry occurs via membrane fusion. This can be measured on a single-virus level in real time using fluorescent probes that report on changes in viral state, such as the exchange of lipids between the virus and a target membrane. We report an assay that measures viral genome exposure to the lumen of a target membrane—the interior of a vesicle or the cytoplasm of a cell. For influenza virus, we find that genome exposure occurs rapidly upon opening of a fusion pore, and the rate of opening is not altered by starting membrane curvature. This assay expands the biophysical toolbox of viral state change measurements, advancing our ability to dissect enveloped viral-entry mechanisms.

Introduction

Enveloped viruses infect cells via a process of membrane fusion between the viral membrane and a cellular membrane, mediated by viral fusion proteins. Activation of the fusion proteins is often rate limiting, but at least two free-energy barriers and corresponding rate-limiting steps have been identified leading to the lipidic intermediates in fusion (1,2,3,4). These are the formation of an initial fusion stalk between the proximal leaflets of the viral and cellular membranes and the formation of a fusion pore, at which point the viral and cellular membranes are topologically continuous. Viral genome release and the potential for replication occur subsequent to fusion pore formation. In some cases, this may be immediate, while in others, downstream events have been identified controlling genome release (5,6).

Single-particle measurements of viral fusion kinetics have proven highly informative in constraining possible fusion mechanisms (7,8,9,10,11,12,13,14,15,16,17). Although bulk kinetics have helped identify the timescales for fusion and many of the factors affecting rate-limiting steps (2,18,19,20,21,22,23,24,25,26,27), the distribution of event waiting times observed in single-particle measurements reports on the degree of functional heterogeneity in the viral population and on which kinetic mechanisms could account for the observed behavior. Analyses in this regard have leveraged substantial prior advances in single-turnover enzymology, which has developed theory and metrics for analyzing such events (8,28,29,30).

Most single-particle measurements of viral fusion kinetics utilize optical probes: fluorescently labeled lipids that dequench upon mixing with an unlabeled target membrane (7,9,10,13,15,16,31), water-soluble dyes loaded at a quenching concentration (7,32), or genetically encoded proteins that change their fluorescent state in a pH-sensitive manner (12,33,34). Aptamer-based detection offers a powerful means to measure viral genomes (35,36) but is more challenging to employ for real-time single-virus detection. Subsequent trafficking of viral genomes has also been measured via quantum dot and other labeling methods (6,37).

For technical reasons, the use of soluble dyes for content mixing has been more challenging, including unstable loading of the dyes into influenza virions (32), thermally induced fusion reported in nonviral systems (38), and challenges in separating fusion from leakage events (32). Soluble dyes such as sulforhodamine B or calcein can be loaded into one fusion partner at a quenching concentration. Either fusion or leakage will cause dequenching and a resulting increase in fluorescence signal as the dye diffuses out. Rupture or full content release also causes a fluorescence decay as the dye diffuses into the surrounding buffer. In these assays, it can often be challenging to differentiate between content leakage without fusion and leakage accompanying fusion as well as potentially between fusion with leakage and fusion without such. An additional factor is that the diffusion of different soluble factors through nascent fusion pores may happen at different stages of the process, particularly when comparing small molecules and large proteins (39,40,41) or DNA-based fluorescence sensors for fusion (42). Nevertheless, these experiments have yielded substantial insight into the factors controlling fusion pore formation.

Here, we report the development and use of a small-molecule dye assay for genome exposure, schematized in Fig. 1. When this dye is encapsulated in a target liposome, genome exposure could occur either via transit of the viral genome through the fusion pore or (more likely) diffusion of the dye into the viral interior and binding to exposed genomic material. Here, we measure the genome exposure kinetics of influenza virus. Influenza contains eight viral RNA segments, each encapsulated in the virion as viral ribonucleoproteins. A matrix layer (M1) further protects the genome but disassembles in response to viral pH drop when the M2 proton channels in the viral membrane are activated (43,44,45,46,47). We demonstrate that nucleic-acid-binding dye can efficiently detect influenza genomes and that this occurs relatively rapidly after fusion pore formation and in the absence of other cellular factors. We also test the dependence of viral genome exposure on target liposome curvature. In accordance with our prior results on influenza lipid mixing (48), but in contrast to prior results on calcium-regulated exocytosis (49,50), we find that target membrane curvature has no detectable effect on the kinetics of genome exposure or fusion pore formation.

Figure 1.

Figure 1

Detection of viral nucleic acid exposure in membrane fusion. DiYO-1 (an oxazole yellow homodimer; a) is a nucleic-acid-binding dye that dramatically increases fluorescence quantum yield upon binding to DNA or RNA. Encapsulation of DiYO in liposomes creates a substrate for fusion that is essentially nonfluorescent until after a fusion pore has been opened and the viral genome is accessible for dye binding, schematized in (b). A sample fluorescence trace is plotted in (c), where the abrupt jump in fluorescence represents an influenza virus fusion and genome exposure event. To see this figure in color, go online.

Materials and methods

Materials

Palmitoyloleoylphophatidylcholine (POPC), dioleoylphosphatidylethanolamine (DOPE), cholesterol (chol), and biotinylated 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine (biotin-DPPE) were purchased from Avanti Polar Lipids (Alabaster, AL, USA). Disialoganglioside GD1a from bovine brain (Cer-Glc-Gal(NeuAc)-GalNAc-Gal-NeuAc) was purchased from Sigma-Aldrich (Burlington, MA, USA). Texas red-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanloamine and Oregon green-1,2- dihexadecanoyl-sn-glycero-3-phosphoethanolamine were purchased from Thermo Fisher Scientific (Waltham, MA, USA). Atto 655 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) was purchased from Atto-Tek (Culpeper, VA, USA). PLL-PEG and PLL-PEG-biotin were purchased from SuSoS (Zurich, Switzerland). DiYO-1 (CAS 143413-85-8) was purchased from AAT Bioquest (Pleasanton, CA, USA). X-31 influenza virus (A/Aichi/68, H3N2) was purchased from Charles River Laboratories (Chicago, IL, USA).

Liposome preparation

Lipids (67 mol % POPC, 20% DOPE, 10% chol, 1% biotin-DPPE, and 2% GD1a) were mixed in chloroform, which was evaporated under nitrogen to a thin film. Residual chloroform was removed by keeping the samples in vacuum for at least 3 h. The lipid films were hydrated in 10 μM DiYO or 16 mM calcein in 10 mM NaH2PO4, 90 mM sodium citrate, 150 mM NaCl (pH 7.45). The lipid suspension at a final lipid concentration of 0.56 mM was subjected to 15 freeze-thaw cycles, and large unilamellar vesicles were obtained by extruding the suspension through polycarbonate membrane filters (Avestin, Mannheim, Germany) with a nominal diameter of 100 or 200 nm. Excess unincorporated dye was removed using a Sephadex G-25 desalting column (Cytiva, Marlborough, MA, USA). Labeled liposomes used for individually correlating liposome diameter and content mixing times were prepared using including 0.5% 655 Atto DOPE in the initial lipid mixture and following the same procedure.

Viral labeling

6 μL Texas red-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanloamine (0.75 mg/mL in ethanol) was mixed with 240 μL of 20 mM HEPES, 150 mM NaCl (pH 7.2). Texas red labeling at this concentration has previously been shown not to affect fusion behavior (51). A small volume of virus suspension (typically 9 μL) at 2 mg total protein/mL was mixed with 4× volume (typically 36 μL) of dye:buffer mixture and incubated for 2 h at room temperature on a rocker. Labeled virus was purified from unincorporated dye by adding 1.3 mL of 20 mM HEPES, 150 mM NaCl (pH 7.2) and centrifuging for 50 min at 21,000 rcf. The pellet containing labeled virus was resuspended in 10 μL of 20 mM HEPES, 150 mM NaCl (pH 7.2) and allowed to rest on ice at 4°C overnight. Labeled virus was either stored on ice at 4°C and used directly or subjected to a single freeze-thaw cycle prior to use. Procedures involving influenza virus were performed under BSL-2 conditions.

Single-virus fusion assays

Fusion assays were performed as previously described (48), with the addition of new content-mixing and genome exposure fluorescent probes. Briefly, glass slides were treated with a mixture of 95% PLL-PEG for passivation and 5% PLL-PEG-biotin for functionalization and then incubated for 15 min with streptavidin at 0.2 mg/mL. Biotinylated liposomes were then tethered to the surface by incubation overnight at 4°C. Texas red-labeled influenza virus was added prior to the start of fusion experiments. At each step, unbound material was washed away using >2 mL phosphate buffer (pH 7.45). Fusion was initiated via a buffer exchange to pH 5 (10 mM NaH2PO4, 90 mM sodium citrate, 150 mM NaCl).

Fluorescence microscopy

Micrographs and videos were acquired using a Zeiss Axio Observer inverted microscope and a 100× oil-immersion objective. Additional optical parameters included excitation/emission filters (Chroma Technology, Bellows Falls, VT, USA) at 480/40 and 535/50 for calcein and DiYO and 560/40 and 630/75 for Texas red and an Arduino-controlled Spectra-X LED Light Engine (Lumencor, Beaverton, OR, USA) as a light source. Images were recorded with a Zyla 4.2 sCMOS camera (Andor Technologies, Belfast, UK) controlled via MicroManager. Some degree of bleaching is observed for DiYO in some but not all cases (Figs. 1 and S2).

Image analysis

Images were analyzed using previously reported single-virus detection and spot-tracking protocols (15,51). MATLAB (Mathworks, Natick, MA, USA) code is available from https://github.com/kassonlab/micrograph-spot-analysis.

Bulk fluorescence measurements

Lyophilized Poly-A RNA (Qiagen) was resuspended at 1 μg/μL in RNAase-free water with 0.04% sodium azide and then diluted in phosphate buffer (10 mM NaH2PO4, 90 mM sodium citrate, and 150 mM NaCl) at pH 5 to reach the designated concentration. The diluted RNA was aliquoted in a 96-well plate, followed by addition of DiYO-1 dye diluted in phosphate buffer, yielding a final dye concentration of 10 μM. Fluorescence was measured using a Clariostar Plus plate reader (BMG Labtech, Ortenberg, Germany) using monochromator settings of 469–497 nm excitation/500–560 nm emission. Cooperativity analyses were performed by nonlinear least-squares fitting to the Hill equation (52) F=a+ba1+(cx)d, where F is the fluorescence signal, x is the concentration of RNA, and a, b, c, and d are fit parameters such that d is the Hill coefficient.

Nanoparticle tracking analysis

Liposomes (prepared from a 0.56 mM lipid suspension) were diluted 1:2,000 in phosphate buffer (pH 7.4). Images were recorded during 30 s for each sample in a NanoSight LM14 Nanoparticle Tracking Analysis Microscope (Malvern Panalytical, Malvern, UK) with a sCMOS camera. The analysis was performed using the instrument software NanoSight NTA (v.3.4). Six technical repeats were included for each condition.

Dynamic light scattering

Liposomes (prepared from a 0.56 mM lipid suspension) were diluted 1:100 in phosphate buffer (pH 7.4). A quartz cuvette was used to measure 20 μL of each sample in an AvidNano W130i instrument (Avid Nano, High Wycombe, UK). The autocorrelation function was measured over 60 s using a 660 nm laser. Three technical replicates were included for each condition.

Results

We first report the characteristics of the genome exposure assay under standardized conditions of RNA-dye binding in the absence of membrane fusion. We then present results for influenza viral genome exposure during fusion, compare with a previously reported content-mixing probe, and test the dependence of fusion kinetics on target membrane curvature.

DiYO-1 (CAS 143413-85-8, marketed by Invitrogen as YOYO-1 and referred to here as DiYO) is a dimeric carbocyanine dye that is well described as intercalating into double-stranded DNA or single-stranded DNA and undergoing an approximately 1,000-fold increase in fluorescence quantum yield (53,54,55,56). Here, we show that it also binds with high affinity to single-stranded RNA (Fig. 2). The Hill coefficient for binding is approximately two, consistent with cooperative dimeric binding and intercalation. Bulk fluorescence experiments (Fig. 2 b) were used to select a dye concentration of 10 μM for liposomal encapsulation. Bulk fluorescence at any dye concentration was negligible in the absence of RNA.

Figure 2.

Figure 2

Dose response of DiYO fluorescence upon incubation with RNA. A 10 μM solution of DiYO dye was incubated with increasing quantities of poly-A RNA to obtain a dose-response curve for DiYO fluorescence. Data (measured in triplicate) are plotted in (a) along with a fitted Hill equation curve. The best-fit Hill coefficient was 2.2 ± 0.3, and the EC50 was 67 μg/mL RNA. The maximal fluorescence increase observed was 340-fold over the lowest amount of RNA tested. Plotted in (b) is the dose response with a fixed amount of poly-A RNA and variable DiYO concentrations. To see this figure in color, go online.

Liposomes (67:20:10:2:1 POPC:DOPE:chol:GD1a:biotin-DPPE) were extruded at 100 or 200 nm as indicated and immobilized in a microfluidic flow cell as previously described (48). The size distribution of liposomes was measured using dynamic light scattering and nanoparticle tracking analysis. The mean diameter values obtained with both methods was different for the 100 and 200 nm populations (Table S2), and both methods indicated a polydisperse sample. When the pH was decreased from 7.4 to 5 either in the exterior environment via simple buffer exchange or intraluminally via buffer exchange in the presence of FCCP ionophore, no change in background fluorescence was observed (Fig. 3). However, a robust increase in fluorescence was observed upon acidification after coincubation with influenza virus (Fig. 1) although not before. This is consistent with detection of influenza genome exposure via a fusion pore.

Figure 3.

Figure 3

Encapsulated DiYO does not show measurable fluorescence gain in the absence of virus. Single-liposome DiYO intensities were measured at pH 7 and after intraluminal pH exchange to pH 5 using acidic buffer in the presence of ionophore FCCP. Overlaid intensity histograms are rendered in (a) and before/after images in (b) and (c), respectively. No significant fluorescence intensity gain was observed for the imaged liposomes in the absence of influenza virus (p > 0.8, Kolmogorov-Smirnov test). Green circles indicate single-liposome spots. To see this figure in color, go online.

Single-event time courses for genome exposure were measured for >100 influenza virus-liposome conjugates per condition and compiled into cumulative distribution functions (Fig. 4). These are compared to cumulative distribution functions measured under identical conditions for lipid dye mixing between the virus and liposome. For both 100 and 200 nm liposomes, genome exposure occurred more slowly than lipid mixing, but the time courses were not statistically distinguishable between liposome sizes (p > 0.5, Kolmogorov-Smirnov test).

Figure 4.

Figure 4

Genome exposure occurs more slowly than lipid mixing but with the rate-limiting step similarly independent of target membrane curvature. Influenza virus was bound to 100 or 200 nm target liposomes, fusion triggered via a drop in pH, and single-event kinetics of either lipid mixing or genome exposure monitored via fluorescence microscopy. No major differences in kinetics were observed between target liposome populations. As expected, genome exposure occurred more slowly than lipid mixing, and not all lipid mixing events led to genome exposure. These observations are consistent with one or more additional free-energy barriers for fusion pore formation and potentially downstream events. Fit parameters and single-event statistics are given in Table S1. To see this figure in color, go online.

Since the size distribution of liposomes extruded at 100 and 200 nm is broad, we also assessed the correlation between liposome size and time to fusion on a single-particle level. Liposomes were labeled with 0.5 mol % Atto 655 DOPE, and then virus-liposome conjugates were analyzed for time to genome exposure. The integrated fluorescence intensity in the Atto channel should increase monotonically with the liposome diameter and scale with the surface area. This intensity value was individually determined for each liposome-virus conjugate (Fig. 5). A nonparametric Spearman rank correlation between liposome fluorescence intensity and time to fusion yielded a value of −0.04, indicating that time to fusion is independent of liposome size over the range tested.

Figure 5.

Figure 5

Single-vesicle analysis shows no correlation between vesicle size and time to fusion. Single virus-liposome conjugates undergoing fusion (assessed via DiYO fluorescence) were analyzed, and the total intensity of membrane fluorophore Atto 655-DOPE was plotted versus the time to fusion for each such conjugate. Atto 655-DOPE was incorporated into liposomes at 0.5 mol %, so fluorescence intensity will report on liposome size, and liposome radius will scale with the square root of total intensity. A Spearman rank correlation of −0.04 was obtained, indicating no relationship between vesicle size and time to fusion. To see this figure in color, go online.

Single-event analysis also indicated that genome exposure requires more kinetic steps contributing to the rate-limiting processes than lipid mixing (Table S1). This is as expected given prior theory (1,57) of the free-energy barriers to fusion pore formation and any potential additional barriers to genome exposure since genome exposure would require all the steps required for lipid mixing, then all those required for fusion pore formation, and possibly additional ones. If fusion pore formation or subsequent exposure of viral genomic RNA to diffusible dye were substantially slower than lipid mixing, those processes could dominate the rate-limiting step. Prior data on exocytic fusion and cells expressing influenza hemagglutinin suggest that pore expansion can be rate limiting (50,57,58,59,60), but that does not appear to be the case here, at least for the transit of DiYO dye.

For comparison, we performed a calcein-content-mixing assay where target liposomes were loaded with calcein dye instead of DiYO and analogous single-particle fluorescence traces were measured. Similar to previous observations in nonviral systems (38,61,62,63), we observed several patterns of fluorescence traces, which we interpret as corresponding to liposome bursting, leakage of liposome contents, and fusion. Under these conditions, the calcein assay does not differentiate leakage and fusion. Characteristic traces are shown in Fig. 6. Under the labeling and illumination conditions used, no illumination-dependent fusion was observed as had been reported previously for SNARE-based fusion (38). If the bursting traces are discarded, then aggregate slow leakage and fusion traces can be assembled into a cumulative distribution function (Fig. 6). The kinetics of calcein combined fusion and leakage events (“fusion + leakage”) are somewhat slower than those of genome exposure, potentially suggesting that late leakage events may occur in virus-liposome conjugates without forming productive fusion pores. These results illustrate the selectivity of the DiYO genome exposure assay for productive fusion events since an increase in DiYO fluorescence requires intraluminal mixing of dye and RNA.

Figure 6.

Figure 6

Calcein dequenching and DiYO RNA binding both show kinetics that do not depend on liposome curvature. Cumulative distribution functions for calcein dequenching and DiYO fluorescence are shown in (a); both display indistinguishable kinetics when measured with 100 and 200 nm liposomes. Representative single-virus calcein dequenching traces are shown in (b). Two profiles are observed: one (top panel) is attributed to liposome rupture, and the other (bottom panel) is attributed to either liposome leakage or fusion; a mixture of such events likely exists in the population. To see this figure in color, go online.

In these experiments, we detected 28–40 lipid mixing events (mean of 35) per 100 Texas red-labeled viral particles (defined as Texas red labeled and immunopositive for hemagglutinin) and 4–20 DiYO genome exposure events (mean of 16) per 100. Compared across biological replicas, there was no significant difference in DiYO fluorescence events versus calcein fusion + leakage events (p > 0.7, Kolmogorov-Smirnov test) and no significant difference in event frequencies between 100 and 200 nm particles (p > 0.4, Kolmogorov-Smirnov test). The lower fraction of viral particles undergoing genome exposure is consistent with prior measurements of lipid versus content mixing in influenza virus (32) and may also reflect physiological inefficiency in successful infection (64,65,66).

Discussion

We have presented the use of an RNA-binding dye to measure the kinetics of influenza genome exposure during viral entry. This assay permits single-virus measurements of a step in viral entry equivalent to or downstream of content mixing between an influenza virion and the content of a target membrane. RNA binding by DiYO is highly sensitive and specifically measures exposure of the viral genome to target membrane contents; target leakage and rupture events do not register in this assay. It thus provides an approach for detecting productive fusion events in viral entry.

Given the relative rapidity and lack of cellular factors required to detect DiYO-influenza RNA binding, we hypothesize that exposure events occur as follows. The M1 layer undergoes partial disassembly, likely prior to fusion itself, and dye then diffuses into the virion at the time of fusion pore formation, binding to exposed portions of the viral ribonucleoproteins. It is of course possible that the viral genome instead diffuses into the lumen of the target liposome, but full disassembly of the influenza virion is thought to require additional factors (5,67) and is likely slower than the events detected here. It would be valuable to develop sensors for viral RNA that could be used for real-time single-virus detection and that are incapable of diffusing through fusion pores. Such probes could be used as additional measures of downstream events in entry of influenza and other enveloped RNA viruses. Aptamer approaches have indeed been used for sensitive detection of viral nucleic acid but have not yet been deployed with single-virus sensitivity (35,36).

Using this approach, we compare the kinetics of influenza genome exposure when the virus fuses to target liposomes of differing size and curvature. In contrast to prior reports on SNARE-mediated fusion (49), we observe identical genome exposure kinetics with 100 and 200 nm target liposomes. We note that other work on SNARE-mediated fusion observed a similar independence of fusion rates on vesicle size (68). In prior work, we demonstrated that influenza virus undergoes lipid mixing at indistinguishable rates to target liposomes of differing size (69) but that membrane deformability is a controlling factor for lipid mixing (48). It is thus not surprising that genome exposure, which occurs no earlier than content mixing and definitely downstream of lipid mixing, would show a similar independence of starting curvature. Classical membrane curvature theory (70) dictates that smaller vesicles should have a more favorable free energy of fusion with influenza virions than larger vesicles because of the curvature stress relieved in the fusion process. Prior theoretical results on protein-free membrane fusion (71,72,73,74) are largely in accordance with this but focus on the curvature energy of highly curved stalk intermediates. The results presented here demonstrate that the starting curvature does not measurably contribute to the rate-limiting steps of either lipid or content mixing in influenza entry. This stands in contrast to the prior results for SNARE-mediated fusion (49). It is of course possible that technical details of the assays and probes used could account for the difference, but the more interesting possibility is that this difference in curvature dependence illuminates the mechanistic differences between SNARE-mediated and viral membrane fusion.

In summary, nucleic acid binding by DiYO-1 yields a highly sensitive and specific assay for exposure of RNA virus genomes. We have leveraged this as a way to measure viral membrane fusion in real time with single-virion resolution, demonstrated here for influenza. We anticipate that this assay will further aid in unraveling the complex mechanisms underpinning enveloped virus entry.

Author contributions

A.M.V.G. designed research, performed experiments, analyzed data, and wrote the manuscript. S.M. performed experiments and analyzed data. P.M.K. designed research, analyzed data, and wrote the manuscript.

Acknowledgments

The authors thank S. Boxer for many helpful conversations. This work was supported by a Wallenberg Academy Fellowship to P.M.K. and by the Swedish Research Council (2017-04236 to P.M.K.).

Declaration of interests

The authors declare no competing interests.

Editor: Rumiana Dimova.

Footnotes

Supporting material can be found online at https://doi.org/10.1016/j.bpj.2022.11.002.

Supporting material

Document S1. Tables S1 and S2 and Figure S1
mmc1.pdf (189.7KB, pdf)
Document S2. Article plus supporting material
mmc2.pdf (1.3MB, pdf)

References

  • 1.Kuzmin P.I., Zimmerberg J., et al. Cohen F.S. A quantitative model for membrane fusion based on low-energy intermediates. Proc. Natl. Acad. Sci. USA. 2001;98:7235–7240. doi: 10.1073/pnas.121191898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mittal A., Bentz J. Comprehensive kinetic analysis of influenza hemagglutinin-mediated membrane fusion: role of sialate binding. Biophys. J. 2001;81:1521–1535. doi: 10.1016/S0006-3495(01)75806-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kozlovsky Y., Chernomordik L.V., Kozlov M.M. Lipid intermediates in membrane fusion: formation, structure, and decay of hemifusion diaphragm. Biophys. J. 2002;83:2634–2651. doi: 10.1016/S0006-3495(02)75274-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Katsov K., Müller M., Schick M. Field theoretic study of bilayer membrane fusion. I. Hemifusion mechanism. Biophys. J. 2004;87:3277–3290. doi: 10.1529/biophysj.103.038943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Banerjee I., Miyake Y., et al. Yamauchi Y. Influenza A virus uses the aggresome processing machinery for host cell entry. Science. 2014;346:473–477. doi: 10.1126/science.1257037. [DOI] [PubMed] [Google Scholar]
  • 6.Babcock H.P., Chen C., Zhuang X. Using single-particle tracking to study nuclear trafficking of viral genes. Biophys. J. 2004;87:2749–2758. doi: 10.1529/biophysj.104.042234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Floyd D.L., Ragains J.R., et al. van Oijen A.M. Single-particle kinetics of influenza virus membrane fusion. Proc. Natl. Acad. Sci. USA. 2008;105:15382–15387. doi: 10.1073/pnas.0807771105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Floyd D.L., Harrison S.C., van Oijen A.M. Analysis of kinetic intermediates in single-particle dwell-time distributions. Biophys. J. 2010;99:360–366. doi: 10.1016/j.bpj.2010.04.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wessels L., Elting M.W., et al. Weninger K. Rapid membrane fusion of individual virus particles with supported lipid bilayers. Biophys. J. 2007;93:526–538. doi: 10.1529/biophysj.106.097485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ivanovic T., Choi J.L., et al. Harrison S.C. Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates. Elife. 2013;2 doi: 10.7554/eLife.00333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ivanovic T., Harrison S.C. Distinct functional determinants of influenza hemagglutinin-mediated membrane fusion. Elife. 2015;4 doi: 10.7554/eLife.11009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Schmidt F.I., Kuhn P., et al. Dittrich P.S. Single-virus fusion experiments reveal proton influx into vaccinia virions and hemifusion lag times. Biophys. J. 2013;105:420–431. doi: 10.1016/j.bpj.2013.06.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chao L.H., Klein D.E., et al. Harrison S.C. Sequential conformational rearrangements in flavivirus membrane fusion. Elife. 2014;3 doi: 10.7554/eLife.04389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Costello D.A., Millet J.K., et al. Daniel S. Single particle assay of coronavirus membrane fusion with proteinaceous receptor-embedded supported bilayers. Biomaterials. 2013;34:7895–7904. doi: 10.1016/j.biomaterials.2013.06.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rawle R.J., Boxer S.G., Kasson P.M. Disentangling viral membrane fusion from receptor binding using synthetic DNA-lipid conjugates. Biophys. J. 2016;111:123–131. doi: 10.1016/j.bpj.2016.05.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rawle R.J., Webster E.R., et al. Boxer S.G. pH dependence of Zika membrane fusion kinetics reveals an off-pathway state. ACS Cent. Sci. 2018;4:1503–1510. doi: 10.1021/acscentsci.8b00494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Haldar S., Okamoto K., et al. Kasson P.M. Precise triggering and chemical control of single-virus fusion within endosomes. J. Virol. 2020;95 doi: 10.1128/JVI.01982-20. e01982-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wharton S.A., Martin S.R., et al. Wiley D.C. Membrane fusion by peptide analogues of influenza virus haemagglutinin. J. Gen. Virol. 1988;69:1847–1857. doi: 10.1099/0022-1317-69-8-1847. [DOI] [PubMed] [Google Scholar]
  • 19.Haywood A.M., Boyer B.P. Fusion of influenza virus membranes with liposomes at pH 7.5. Proc. Natl. Acad. Sci. USA. 1985;82:4611–4615. doi: 10.1073/pnas.82.14.4611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Stegmann T., Morselt H.W., et al. Wilschut J. Fusion of influenza virus in an intracellular acidic compartment measured by fluorescence dequenching. Biochim. Biophys. Acta. 1987;904:165–170. doi: 10.1016/0005-2736(87)90100-3. [DOI] [PubMed] [Google Scholar]
  • 21.Ellens H., Bentz J., et al. White J.M. Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density. Biochemistry. 1990;29:9697–9707. doi: 10.1021/bi00493a027. [DOI] [PubMed] [Google Scholar]
  • 22.Puri A., Booy F.P., et al. Blumenthal R. Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment. J. Virol. 1990;64:3824–3832. doi: 10.1128/jvi.64.8.3824-3832.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kozerski C., Ponimaskin E., et al. Herrmann A. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore. J. Virol. 2000;74:7529–7537. doi: 10.1128/jvi.74.16.7529-7537.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yang X., Kurteva S., et al. Sodroski J. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1. J. Virol. 2005;79:12132–12147. doi: 10.1128/JVI.79.19.12132-12147.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Magnus C., Rusert P., et al. Regoes R.R. Estimating the stoichiometry of human immunodeficiency virus entry. J. Virol. 2009;83:1523–1531. doi: 10.1128/JVI.01764-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Danieli T., Pelletier S.L., et al. White J.M. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell Biol. 1996;133:559–569. doi: 10.1083/jcb.133.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Domanska M.K., Wrona D., Kasson P.M. Multiphasic effects of cholesterol on influenza fusion kinetics reflect multiple mechanistic roles. Biophys. J. 2013;105:1383–1387. doi: 10.1016/j.bpj.2013.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kou S.C., Cherayil B.J., et al. Xie X.S. Single-molecule Michaelis-Menten equations. J. Phys. Chem. B. 2005;109:19068–19081. doi: 10.1021/jp051490q. [DOI] [PubMed] [Google Scholar]
  • 29.Shaevitz J.W., Block S.M., Schnitzer M.J. Statistical kinetics of macromolecular dynamics. Biophys. J. 2005;89:2277–2285. doi: 10.1529/biophysj.105.064295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Moffitt J.R., Bustamante C. Extracting signal from noise: kinetic mechanisms from a Michaelis-Menten-like expression for enzymatic fluctuations. FEBS J. 2014;281:498–517. doi: 10.1111/febs.12545. [DOI] [PubMed] [Google Scholar]
  • 31.Costello D.A., Lee D.W., et al. Daniel S. Influenza virus-membrane fusion triggered by proton uncaging for single particle studies of fusion kinetics. Anal. Chem. 2012;84:8480–8489. doi: 10.1021/ac3006473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Liu K.N., Boxer S.G. Single-virus content mixing assay reveals cholesterol-enhanced influenza membrane fusion efficiency. Biophys. J. 2021;120:4832–4841. doi: 10.1101/2021.04.26.441491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Melikyan G.B., Barnard R.J.O., et al. Young J.A.T. Imaging individual retroviral fusion events: from hemifusion to pore formation and growth. Proc. Natl. Acad. Sci. USA. 2005;102:8728–8733. doi: 10.1073/pnas.0501864102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Jha N.K., Latinovic O., et al. Melikyan G.B. Imaging single retrovirus entry through alternative receptor isoforms and intermediates of virus-endosome fusion. PLoS Pathog. 2011;7 doi: 10.1371/journal.ppat.1001260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Negri P., Chen G., et al. Dluhy R.A. Direct optical detection of viral nucleoprotein binding to an anti-influenza aptamer. Anal. Chem. 2012;84:5501–5508. doi: 10.1021/ac202427e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Le T.T., Adamiak B., et al. Cass A.E.G. Aptamer-based biosensors for the rapid visual detection of flu viruses. Chem. Commun. 2014;50:15533–15536. doi: 10.1039/C4CC07888H. [DOI] [PubMed] [Google Scholar]
  • 37.Qin C., Li W., et al. Cui Z. Real-time dissection of dynamic uncoating of individual influenza viruses. Proc. Natl. Acad. Sci. USA. 2019;116:2577–2582. doi: 10.1073/pnas.1812632116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bowen M.E., Weninger K., et al. Chu S. Single molecule observation of liposome-bilayer fusion thermally induced by soluble N-ethyl maleimide sensitive-factor attachment protein receptors (SNAREs) Biophys. J. 2004;87:3569–3584. doi: 10.1529/biophysj.104.048637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Diao J., Ishitsuka Y., et al. Ha T. A single vesicle-vesicle fusion assay for in vitro studies of SNAREs and accessory proteins. Nat. Protoc. 2012;7:921–934. doi: 10.1038/nprot.2012.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Blumenthal R., Sarkar D.P., et al. Morris S.J. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events. J. Cell Biol. 1996;135:63–71. doi: 10.1083/jcb.135.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Plonsky I., Kingsley D.H., et al. Zimmerberg J. Initial size and dynamics of viral fusion pores are a function of the fusion protein mediating membrane fusion. Biol. Cell. 2008;100:377–386. doi: 10.1042/BC20070040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Lai Y., Diao J., et al. Shin Y.K. Fusion pore formation and expansion induced by Ca2+ and synaptotagmin 1. Proc. Natl. Acad. Sci. USA. 2013;110:1333–1338. doi: 10.1073/pnas.1218818110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Fontana J., Cardone G., et al. Steven A.C. Structural changes in Influenza virus at low pH characterized by cryo-electron tomography. J. Virol. 2012;86:2919–2929. doi: 10.1128/JVI.06698-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Fontana J., Steven A.C. At low pH, influenza virus matrix protein M1 undergoes a conformational change prior to dissociating from the membrane. J. Virol. 2013;87:5621–5628. doi: 10.1128/JVI.00276-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Li S., Sieben C., et al. Schaap I.A.T. pH-controlled two-step uncoating of influenza virus. Biophys. J. 2014;106:1447–1456. doi: 10.1016/j.bpj.2014.02.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Stauffer S., Feng Y., et al. Helenius A. Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration. J. Virol. 2014;88:13029–13046. doi: 10.1128/JVI.01430-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Bui M., Whittaker G., Helenius A. Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J. Virol. 1996;70:8391–8401. doi: 10.1128/jvi.70.12.8391-8401.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Villamil Giraldo A.M., Kasson P.M. Bilayer-coated nanoparticles reveal how influenza viral entry depends on membrane deformability but not curvature. J. Phys. Chem. Lett. 2020;11:7190–7196. doi: 10.1021/acs.jpclett.0c01778. [DOI] [PubMed] [Google Scholar]
  • 49.Kreutzberger A.J.B., Kiessling V., et al. Tamm L.K. In vitro fusion of single synaptic and dense core vesicles reproduces key physiological properties. Nat. Commun. 2019;10:3904. doi: 10.1038/s41467-019-11873-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Zhang Z., Jackson M.B. Membrane bending energy and fusion pore kinetics in Ca(2+)-triggered exocytosis. Biophys. J. 2010;98:2524–2534. doi: 10.1016/j.bpj.2010.02.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Rawle R.J., Villamil Giraldo A.M., et al. Kasson P.M. Detecting and controlling dye effects in single-virus fusion experiments. Biophys. J. 2019;117:445–452. doi: 10.1016/j.bpj.2019.06.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hill A.V. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J. Physiol. 1910;40 iv–vii. [Google Scholar]
  • 53.Carlsson C., Larsson A., et al. Norden B. Optical and photophysical properties of the oxazole yellow DNA probes YO and YOYO. J. Phys. Chem. 1994;98:10313–10321. [Google Scholar]
  • 54.Günther K., Mertig M., Seidel R. Mechanical and structural properties of YOYO-1 complexed DNA. Nucleic Acids Res. 2010;38:6526–6532. doi: 10.1093/nar/gkq434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Glazer A.N., Rye H.S. Stable dye–DNA intercalation complexes as reagents for high-sensitivity fluorescence detection. Nature. 1992;359:859–861. doi: 10.1038/359859a0. [DOI] [PubMed] [Google Scholar]
  • 56.Rye H.S., Glazer A.N. Interaction of dimeric intercalating dyes with single-stranded DNA. Nucleic Acids Res. 1995;23:1215–1222. doi: 10.1093/nar/23.7.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Cohen F.S., Melikyan G.B. The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement. J. Membr. Biol. 2004;199:1–14. doi: 10.1007/s00232-004-0669-8. [DOI] [PubMed] [Google Scholar]
  • 58.Biswas S., Yin S.R., et al. Zimmerberg J. Cholesterol promotes hemifusion and pore widening in membrane fusion induced by influenza hemagglutinin. J. Gen. Physiol. 2008;131:503–513. doi: 10.1085/jgp.200709932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Chernomordik L.V., Frolov V.A., et al. Zimmerberg J. The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J. Cell Biol. 1998;140:1369–1382. doi: 10.1083/jcb.140.6.1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Nanavati C., Markin V.S., et al. Fernandez J.M. The exocytotic fusion pore modeled as a lipidic pore. Biophys. J. 1992;63:1118–1132. doi: 10.1016/S0006-3495(92)81679-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Wang T., Smith E.A., et al. Weisshaar J.C. Lipid mixing and content release in single-vesicle, SNARE-driven fusion assay with 1–5 ms resolution. Biophys. J. 2009;96:4122–4131. doi: 10.1016/j.bpj.2009.02.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Yu H., Rathore S.S., Shen J. Synip arrests soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-dependent membrane fusion as a selective target membrane SNARE-binding inhibitor. J. Biol. Chem. 2013;288:18885–18893. doi: 10.1074/jbc.M113.465450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Rawle R.J., van Lengerich B., et al. Boxer S.G. Vesicle fusion observed by content transfer across a tethered lipid bilayer. Biophys. J. 2011;101:L37–L39. doi: 10.1016/j.bpj.2011.09.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Wei Z., McEvoy M., et al. Schenerman M.A. Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: correlation of particle counts, size distribution and infectivity. J. Virol. Methods. 2007;144:122–132. doi: 10.1016/j.jviromet.2007.04.008. [DOI] [PubMed] [Google Scholar]
  • 65.Brooke C.B., Ince W.L., et al. Yewdell J.W. Most influenza a virions fail to express at least one essential viral protein. J. Virol. 2013;87:3155–3162. doi: 10.1128/JVI.02284-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Enami M., Sharma G., et al. Palese P. An influenza virus containing nine different RNA segments. Virology. 1991;185:291–298. doi: 10.1016/0042-6822(91)90776-8. [DOI] [PubMed] [Google Scholar]
  • 67.Miyake Y., Keusch J.J., et al. Yamauchi Y. Influenza virus uses transportin 1 for vRNP debundling during cell entry. Nat. Microbiol. 2019;4:578–586. doi: 10.1038/s41564-018-0332-2. [DOI] [PubMed] [Google Scholar]
  • 68.Stratton B.S., Warner J.M., et al. O'Shaughnessy B. Cholesterol increases the openness of SNARE-mediated flickering fusion pores. Biophys. J. 2016;110:1538–1550. doi: 10.1016/j.bpj.2016.02.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Pabis A., Rawle R.J., Kasson P.M. Influenza hemagglutinin drives viral entry via two sequential intramembrane mechanisms. Proc. Natl. Acad. Sci. USA. 2020;117:7200–7207. doi: 10.1073/pnas.1914188117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Helfrich W. Elastic properties of lipid bilayers: theory and possible experiments. Z. Naturforsch. C. 1973;28:693–703. doi: 10.1515/znc-1973-11-1209. [DOI] [PubMed] [Google Scholar]
  • 71.Malinin V.S., Lentz B.R. Energetics of vesicle fusion intermediates: comparison of calculations with observed effects of osmotic and curvature stresses. Biophys. J. 2004;86:2951–2964. doi: 10.1016/S0006-3495(04)74346-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Siegel D.P. Energetics of intermediates in membrane-fusion - comparison of stalk and inverted micellar intermediate mechanisms. Biophys. J. 1993;65:2124–2140. doi: 10.1016/S0006-3495(93)81256-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Markin V.S., Kozlov M.M., Borovjagin V.L. On the theory of membrane fusion. The stalk mechanism. Gen. Physiol. Biophys. 1984;3:361–377. [PubMed] [Google Scholar]
  • 74.Kozlovsky Y., Kozlov M.M. Stalk model of membrane fusion: solution of energy crisis. Biophys. J. 2002;82:882–895. doi: 10.1016/S0006-3495(02)75450-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Document S1. Tables S1 and S2 and Figure S1
mmc1.pdf (189.7KB, pdf)
Document S2. Article plus supporting material
mmc2.pdf (1.3MB, pdf)

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES